This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...